SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Verastem (VSTM)

VSTM RSS Feed
Add VSTM Price Alert      Hide Sticky   Hide Intro
Moderator: n3m3sis
Search This Board: 
Last Post: 12/13/2017 1:56:32 PM - Followers: 33 - Board type: Free - Posts Today: 0

Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) in breast and other cancers along with proprietary companion diagnostics. Its product candidate is VS-507, a small molecule anti-cancer drug, which is in preclinical studies for the treatment of breast cancer. VS-507 would target the CSCs that have been implicated in aggressive cancer, metastases, and chemotherapeutic resistance. The company was founded in 2010 and is based in Cambridge, Massachusetts.
SureTrader
Interactive Brokers Advertisement
VSTM
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VSTM News: Verastem Announces the Presentation of Phase 1 Duvelisib Combination Data in T-Cell Lymphomas at the ASH 2017 Annual Meeting 12/11/2017 05:00:00 PM
VSTM News: Verastem Announces Clinical Data from the Pivotal Phase 3 DUO™ Study: Duvelisib Significantly Improves Progression Free Sur... 12/10/2017 04:30:00 PM
VSTM News: Statement of Changes in Beneficial Ownership (4) 12/07/2017 04:04:09 PM
VSTM News: Verastem to Present Results from Pivotal Phase 3 DUO Study in Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma at a ... 12/05/2017 07:00:00 AM
VSTM News: Research Report Identifies Hill-Rom, TASER International, Synchronoss Technologies, NuVasive, Verastem, and Roku with Renewed... 11/20/2017 07:55:00 AM
PostSubject
#190   Verastem: Revisiting This Small Biotech Name After ASH stockguard 12/13/17 01:56:32 PM
#189   Just posting this as i`m keeping up on stockguard 12/13/17 01:55:30 PM
#188   R u doing this clay? Barry Allen 12/13/17 10:09:20 AM
#187   More strain on $VSTM’s drug combination. stockguard 12/12/17 08:39:08 PM
#186   * * $VSTM Video Chart 12-11-17 * * ClayTrader 12/11/17 05:18:38 PM
#185   Thank you for that post Stockguard! n3m3sis 12/11/17 05:07:24 PM
#184   n3m3sis If you have a concept of the science stockguard 12/11/17 04:46:58 PM
#183   That 'article' only serves to show.... n3m3sis 12/11/17 04:42:16 PM
#182   I now have to rethink my holding even stockguard 12/11/17 02:50:36 PM
#181   Sadly, this fell apart too quick. 2obee1 12/11/17 10:29:06 AM
#180   Come on. Someone sell to me. OTCPennyPincher 12/11/17 09:42:57 AM
#179   CEO bought 230k in shares about a week 2obee1 12/10/17 10:08:37 PM
#178   I am very glad that I bought some 2obee1 12/10/17 10:07:29 PM
#177   Price target? chip22 12/10/17 08:50:45 PM
#176   Expect the PPS to take off into the n3m3sis 12/10/17 08:28:00 PM
#175   Well worth a purchase still at this low valuation. stockguard 12/10/17 05:46:53 PM
#174   Interesting little bit of information there. I OTCPennyPincher 12/10/17 05:44:33 PM
#173   Just popped up on my scanner here. OTCPennyPincher 12/10/17 05:43:43 PM
#172   Congrats to all you VSTM investors. Got rebelwithacause 12/10/17 05:30:52 PM
#171   Verastem: Too Cheap stockguard 12/04/17 01:21:42 PM
#170   This looks promising for Verastem: stockguard 12/01/17 12:38:11 PM
#164   Sorry!!! Estimate of worth way too low! n3m3sis 09/25/17 05:22:15 PM
#163   Celebration I think......... n3m3sis 09/25/17 05:15:53 PM
#162   $VSTM Afterhours jump a cause for celebration or alarm? michaeldesanta 09/13/17 07:08:28 PM
#161   If you look at Novartis' Q2 2017 IR BobDoleYahoo 09/13/17 02:48:34 AM
#160   Let's get that $10 plus .. nymostwanted 09/12/17 08:47:06 AM
#159   Verastem crashes the lymphoma party stockguard 09/09/17 11:19:51 AM
#158   'BobDoleYahoo To the friggen moon!!!!!!!!!!!! stockguard 09/09/17 10:29:25 AM
#157   $2 billion buyout = $54 dollars per share BobDoleYahoo 09/09/17 05:35:30 AM
#156   **** MUST READ !!! **** BobDoleYahoo 09/09/17 05:31:23 AM
#155   https://seekingalpha.com/article/4104948-verastem-beats-odds Inoviorulez 09/07/17 06:43:06 PM
#153   * * $VSTM Video Chart 09-06-17 * * ClayTrader 09/06/17 05:03:41 PM
#152   Is it any wonder somebody does not want n3m3sis 09/06/17 03:38:01 PM
#151   With this volume and power thought this would Tdash 09/06/17 02:33:36 PM
#150   Verastem upgraded to Overweight after duvelisib data at Cantor n3m3sis 09/06/17 10:20:41 AM
#149   VSTM Took starter pre market I think this BoilerRoom 09/06/17 09:01:52 AM
#148   Verastem's Duvelisib Receives Fast Track Designation from the FDA n3m3sis 09/06/17 07:34:52 AM
#147   UPDATE 1-Verastem's blood cancer drug succeeds in late-stage trial n3m3sis 09/06/17 07:26:32 AM
#146   VSTM Loaded at 3.80 AH. Come on FDA INTL 08/31/17 05:00:57 PM
#145   Flexibility requires being open to all outcomes, from stockguard 08/15/17 05:23:48 PM
#144   Trading volume has been low the past few stockguard 08/15/17 11:50:05 AM
#143   >> could spring higher on good buying volume. << dangreene 08/14/17 04:18:06 PM
#142   Shorts keeping a tight leash on this still stockguard 08/14/17 03:50:48 PM
#141   Sellers exhausted and a oversold chart, now needs stockguard 08/14/17 02:22:15 PM
#140   See if next week brings a bounce off stockguard 08/11/17 06:49:04 PM
#139   With the shorts taking on more of a stockguard 08/11/17 03:06:04 PM
#138   7/31/2017 1,609,275 shares short conix 08/10/17 07:38:56 PM
#137   I`ve been picking up blocks since yesterday as stockguard 08/10/17 07:26:40 PM
#136   VSTM approaching a buy point for a trade. conix 08/10/17 05:21:31 PM
#135   Good area to pick up some trading shares. stockguard 08/09/17 02:18:49 PM
PostSubject